CONFLICT OF INTEREST STATEMENT
C.V.G
ONCOLOGY
C.V.G: Reports grants, personal fees, and non‐financial support from AstraZeneca; grants, personal fees, and non‐financial support from Roche; personal fees and non‐financial support from MSD Oncology; personal fees and non‐financial support from Pfizer; non‐financial support from Novartis; and personal fees from Eli Lilly outside the submitted work. A.S.F: Reports consulting with Roche Mexico. S.N.D: Reports consultancy role for AstraZeneca, Genentech, GlaxoSmithKline, Medscape, Merck‐Sharp, Novartis, Pfizer, Roche, Janssen; institutional financial support from Amgen, AstraZeneca, Bristol‐Myers Squibb, Daiichi, Novartis, Merck, Millenium, Pfizer, Roche, Pfizer; being Chair for ABC Global Alliance and ABC Consensus. M.S.G: Reports honoraria from Roche, ESAI, AMGEN. Y.R.B: Reports support for meetings or travel from Bristol‐Myers Squibb and Bayer. J.T.S: Reports grant support and honoraria from Roche Mexico. Other authors: No disclosures.